Literature DB >> 11565628

Serotonergic involvement in the psychosocial dimension of personality.

W S Tse1, A J Bond.   

Abstract

Neurotransmitter systems have been associated with aspects of personality and changes in various dimensions have been shown after antidepressant treatment. A reduction in harm avoidance and an increase in self-directedness and cooperativeness, as measured by the Cloninger's Temperament and Character Inventory (TCI), have been reported in psychiatric patients receiving treatment with serotonergic antidepressants. However, some of these changes have been associated with clinical improvement. The present study therefore used a randomized, double-blind, placebo-controlled design to examine the role of the serotonergic system on these personality factors in the normal population. Twenty healthy male volunteers were randomly allocated to either placebo (n = 9) or citalopram treatment (n = 11) for 2 weeks. Baseline depression and anxiety scores were low and did not differ between groups. The TCI was administered pre- and post-treatment. There were no baseline differences on any TCI factor between groups. Citalopram induced a significant increase in self-directedness (p < 0.05) but not cooperativeness or harm avoidance ratings after treatment. Thus, citalopram has effects on personality aspects which appear to be separate from its antidepressant properties.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11565628     DOI: 10.1177/026988110101500313

Source DB:  PubMed          Journal:  J Psychopharmacol        ISSN: 0269-8811            Impact factor:   4.153


  10 in total

Review 1.  Possible role of more positive social behaviour in the clinical effect of antidepressant drugs.

Authors:  Simon N Young; Debbie S Moskowitz; Marije aan het Rot
Journal:  J Psychiatry Neurosci       Date:  2014-01       Impact factor: 6.186

2.  The effects of sertraline on psychopathic traits.

Authors:  Boadie W Dunlop; Jared A DeFife; Lauren Marx; Steven J Garlow; Charles B Nemeroff; Scott O Lilienfeld
Journal:  Int Clin Psychopharmacol       Date:  2011-11       Impact factor: 1.659

3.  Personality change during depression treatment: a placebo-controlled trial.

Authors:  Tony Z Tang; Robert J DeRubeis; Steven D Hollon; Jay Amsterdam; Richard Shelton; Benjamin Schalet
Journal:  Arch Gen Psychiatry       Date:  2009-12

Review 4.  Biomarkers for the effects of selective serotonin reuptake inhibitors (SSRIs) in healthy subjects.

Authors:  G J H Dumont; S J de Visser; A F Cohen; J M A van Gerven
Journal:  Br J Clin Pharmacol       Date:  2005-05       Impact factor: 4.335

5.  Chronic modulation of serotonergic neurotransmission with sertraline attenuates the loudness dependence of the auditory evoked potential in healthy participants.

Authors:  Julian G Simmons; Pradeep J Nathan; Gregor Berger; Nicholas B Allen
Journal:  Psychopharmacology (Berl)       Date:  2011-04-05       Impact factor: 4.530

Review 6.  Serotonergic function, two-mode models of self-regulation, and vulnerability to depression: what depression has in common with impulsive aggression.

Authors:  Charles S Carver; Sheri L Johnson; Jutta Joormann
Journal:  Psychol Bull       Date:  2008-11       Impact factor: 17.737

7.  Effects of paroxetine on emotional functioning and treatment awareness: a 4-week randomized placebo-controlled study in healthy clinicians.

Authors:  Nathalie Besnier; Catherine Cassé-Perrot; Elisabeth Jouve; Nhan Nguyen; Christophe Lançon; Bruno Falissard; Olivier Blin
Journal:  Psychopharmacology (Berl)       Date:  2009-10-14       Impact factor: 4.530

8.  Effect of chronic escitalopram versus placebo on personality traits in healthy first-degree relatives of patients with depression: a randomized trial.

Authors:  Ulla Knorr; Maj Vinberg; Erik Lykke Mortensen; Per Winkel; Christian Gluud; Jørn Wetterslev; Ulrik Gether; Lars Vedel Kessing
Journal:  PLoS One       Date:  2012-02-29       Impact factor: 3.240

9.  Mood and Global Symptom Changes among Psychotherapy Clients with Depressive Personality.

Authors:  Rachel E Maddux; Lars-Gunnar Lundh
Journal:  Depress Res Treat       Date:  2012-12-12

Review 10.  Fluoxetine Administration in Juvenile Monkeys: Implications for Pharmacotherapy in Children.

Authors:  Mari S Golub; Casey E Hogrefe; Richard J Sherwood; Christoph W Turck
Journal:  Front Pediatr       Date:  2018-02-08       Impact factor: 3.418

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.